Table 3

Development of new syndesmophytes over time

No of new syndesmophytesAll intervals with at least 1 uninvolved VC* (n (%)) (n=468)All intervals with at least 1 uninvolved VC* in ‘12 year completers’† (n (%)) (n=240)First 2 year interval (Y0–Y2) with at least 1 uninvolved VC* (n (%)) (n=153)
Reader 1Reader 2Reader 1Reader 2Reader 1Reader 2
 0292 (62)286 (61)141 (59)141 (59)109 (71)102 (67)
 175 (16)95 (20)48 (20)48 (20)16 (10)23 (15)
 256 (12)52 (11)25 (10)28 (12)19 (12)18 (12)
 323 (5)15 (3)12 (5)9 (4)4 (3)5 (3)
 410 (2)9 (2)5 (2)6 (3)2(1)2 (1)
 54 (1)4 (1)2 (1)2 (1)2 (1)2 (1)
 62 (0)2 (0)2 (1)1 (0)0 (0)0 (0)
 71 (0)2 (0)1 (0)2 (1)0 (0)0 (0)
 83 (1)2 (0)2 (1)2 (1)0 (0)0 (0)
 120 (0)1 (0)0 (0)1 (0)0 (0)1 (1)
 131 (0)0 (0)1 (0)0 (0)1 (1)0 (0)
 141 (0)0 (0)1 (0)0 (0)0 (0)0 (0)
All patients with at least 1 uninvolved VC (n (%)) (n=173)All patients with at least 1 uninvolved VC and with mSASSS available at Y12 (n (%) (n=62) First 2 year interval (Y0–Y2) with at least 1 uninvolved VC* (n (%)) (n=153)
Reader 1Reader 2Reader 1Reader 1Reader 1Reader 2
No of patients with new syndesmophytes96 (55)109 (63)43 (69)46 (74)44 (29)51 (33)
  • *Uninvolved VC is a VC without a previous syndesmophyte or bridge, at risk for developing a new syndesmophyte, according to both readers.

  • †Patients with mSASSS at year 12 available.

  • mSASSS, modified Stoke Ankylosing Spondylitis Spine Score; VC, vertebral corner.